Zullino D

Faculty of Medicine, University of Geneva, Geneva, Switzerland.

7 papers · 2 preprints

ArticlePsilocybin

Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.

Eskinazi M, Nasserdine R, Cusin RM +19

Europe PMC2026
ArticlePsilocybin

Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review.

Sabé M, Grof P, Sackett NB +24

Europe PMC2026
ArticlePsilocybin

Real-world effectiveness and safety of psychedelic-assisted psychotherapy: Outcomes from a large-scale compassionate use cohort in Switzerland.

Aboulafia-Brakha T, Buchard A, Mabilais C +11

Europe PMC2026
PreprintPsilocybin

Real-World Effectiveness and Safety of Psychedelic-Assisted Psychotherapy: Outcomes from a Large-Scale Compassionate Use Cohort in Switzerland

Aboulafia-Brakha T, Buchard A, Mabilais C +11

Europe PMC2025
PreprintPsilocybin

Limited prognostic value of early maladaptive schemas for acute psychedelic experience and symptom improvement

Buchard A, Seragnoli F, Sabe M +8

Europe PMC2025
ArticlePsychedelics

Treatment of depressive and negative symptoms in individuals with schizoaffective disorders using serotoninergic psychedelics: a case report.

Sabé M, Seragnoli F, Thorens G +6

Europe PMC2025
ArticlePsilocybin

Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.

Sabé M, Sulstarova A, Glangetas A +15

Europe PMC2025
ArticlePsilocybin

Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies.

Perez N, Langlest F, Mallet L +9

Europe PMC2023
ArticleKetamine

A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs.

Solmi M, Chen C, Daure C +14

Europe PMC2022